You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

CLEOCIN HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Cleocin Hydrochloride, and when can generic versions of Cleocin Hydrochloride launch?

Cleocin Hydrochloride is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in CLEOCIN HYDROCHLORIDE is clindamycin hydrochloride. There are fifty-five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clindamycin hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cleocin Hydrochloride

A generic version of CLEOCIN HYDROCHLORIDE was approved as clindamycin hydrochloride by COSETTE on September 20th, 1989.

  Try a Trial

Summary for CLEOCIN HYDROCHLORIDE
Drug patent expirations by year for CLEOCIN HYDROCHLORIDE
Recent Clinical Trials for CLEOCIN HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of Missouri-ColumbiaPhase 4
University of California, Los AngelesPhase 4
Roswell Park Cancer InstitutePhase 4

See all CLEOCIN HYDROCHLORIDE clinical trials

Pharmacology for CLEOCIN HYDROCHLORIDE

US Patents and Regulatory Information for CLEOCIN HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer CLEOCIN HYDROCHLORIDE clindamycin hydrochloride CAPSULE;ORAL 050162-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer CLEOCIN HYDROCHLORIDE clindamycin hydrochloride CAPSULE;ORAL 050162-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Pfizer CLEOCIN HYDROCHLORIDE clindamycin hydrochloride CAPSULE;ORAL 050162-003 Apr 14, 1988 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.